Alendronate in primary hyperparathyroidism: a double-blind, randomized, placebo-controlled trial.
Khan AA, Bilezikian JP, Kung AW, Ahmed MM, Dubois SJ, Ho AY, Schussheim D, Rubin MR, Shaikh AM, Silverberg SJ, Standish TI, Syed Z, Syed ZA.
Khan AA, et al. Among authors: bilezikian jp.
J Clin Endocrinol Metab. 2004 Jul;89(7):3319-25. doi: 10.1210/jc.2003-030908.
J Clin Endocrinol Metab. 2004.
PMID: 15240609
Clinical Trial.